Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-06-11 Purchase |
2024-06-12 4:30 pm |
Biomea Fusion Inc. | BMEA | Valle Franco Chief Financial Officer |
12,509 | $4.4257 | $55,361 | 42,500 (Direct) |
View |
2022-11-11 Purchase |
2022-11-14 4:30 pm |
Biomea Fusion Inc. | BMEA | Valle Franco Chief Financial Officer |
4,100 | $7.6307 | $31,286 | 17,407 (Direct) |
View |
2022-01-14 Purchase |
2022-01-18 7:00 pm |
Biomea Fusion Inc. | BMEA | Valle Franco Chief Financial Officer |
10,000 | $8.6767 | $86,767 | 10,000 (Direct) |
View |
2021-01-11 Sale |
2021-01-13 4:05 pm |
Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance |
3,247 | $125.52 | $407,560 | 50,447 (Direct) |
View |
2020-11-09 Sale |
2020-11-10 4:05 pm |
Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance |
1,623 | $74.93 | $121,609 | 27,597 (Direct) |
View |
2020-10-07 Sale |
2020-10-09 5:23 pm |
Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance |
10,643 | $74.97 | $797,899 | 63,639 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-11-30 Option Award |
2024-12-02 4:30 pm |
N/A N/A |
Biomea Fusion Inc. | BMEA | Valle Franco Chief Financial Officer |
495 | $6.154 | 42,995 (Direct) |
View |
2024-05-31 Option Award |
2024-06-12 4:30 pm |
N/A N/A |
Biomea Fusion Inc. | BMEA | Valle Franco Chief Financial Officer |
4,448 | $3.7825 | 42,500 (Direct) |
View |
2024-01-17 Option Award |
2024-01-18 4:30 pm |
N/A 2034-01-16 |
Biomea Fusion Inc. | BMEA | Valle Franco Chief Financial Officer |
145,245 | $0 | 145,245 (Direct) |
View |
2023-11-30 Option Award |
2023-12-01 5:58 pm |
N/A N/A |
Biomea Fusion Inc. | BMEA | Valle Franco Chief Financial Officer |
1,345 | $3.7825 | 25,543 (Direct) |
View |
2023-05-31 Option Award |
2023-06-02 5:01 pm |
N/A N/A |
Biomea Fusion Inc. | BMEA | Valle Franco Chief Financial Officer |
4,273 | $3.7825 | 24,198 (Direct) |
View |
2023-01-06 Option Award |
2023-01-10 5:00 pm |
N/A 2033-01-05 |
Biomea Fusion Inc. | BMEA | Valle Franco Chief Financial Officer |
126,300 | $0 | 126,300 (Direct) |
View |
2022-11-30 Option Award |
2022-12-02 4:30 pm |
N/A N/A |
Biomea Fusion Inc. | BMEA | Valle Franco Chief Financial Officer |
2,518 | $3.7825 | 19,925 (Direct) |
View |
2022-05-31 Option Award |
2022-06-01 6:00 pm |
N/A N/A |
Biomea Fusion Inc. | BMEA | Valle Franco Chief Financial Officer |
3,307 | $4.6665 | 13,307 (Direct) |
View |
2021-12-04 Option Award |
2021-12-07 5:25 pm |
N/A 2031-12-03 |
Biomea Fusion Inc. | BMEA | Valle Franco Chief Financial Officer |
144,770 | $0 | 144,770 (Direct) |
View |
2021-08-03 Option Award |
2021-08-05 7:25 pm |
N/A 2031-07-25 |
Biomea Fusion Inc. | BMEA | Valle Franco Chief Financial Officer |
165,000 | $0 | 165,000 (Direct) |
View |
2021-01-11 Exercise |
2021-01-13 4:05 pm |
N/A N/A |
Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance |
3,247 | $7.24 | 50,447 (Direct) |
View |
2021-01-11 Exercise |
2021-01-13 4:05 pm |
N/A 2028-05-06 |
Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance |
3,247 | $0 | 50,447 (Direct) |
View |
2020-11-09 Exercise |
2020-11-10 4:05 pm |
N/A N/A |
Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance |
1,623 | $7.24 | 27,597 (Direct) |
View |
2020-11-09 Exercise |
2020-11-10 4:05 pm |
N/A 2028-05-06 |
Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance |
1,623 | $0 | 27,597 (Direct) |
View |
2020-10-07 Exercise |
2020-10-09 5:23 pm |
N/A N/A |
Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance |
10,199 | $7.24 | 63,639 (Direct) |
View |
2020-10-07 Exercise |
2020-10-09 5:23 pm |
N/A 2028-05-06 |
Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance |
10,199 | $0 | 63,639 (Direct) |
View |
2020-05-31 Option Award |
2020-06-05 4:05 pm |
N/A N/A |
Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance |
444 | $41.57 | 444 (Direct) |
View |